Mater Research has shed new light on the role of the specialised immune cells osteal macrophages (osteomacs) in the often-debilitating bone degenerative disease osteoporosis.

Bone marrow failure is one of the most common side effects of cancer therapy causing hospitalisation, and at its most severe can lead to death.

Mater Research is proud to sponsor the ‘Employer of Choice Small/Medium Business’ category, as part of the 23rd Annual Women in Technology awards.